$-0.07 EPS Expected for CAS Medical Systems, Inc. (CASM)

July 14, 2018 - By Robert Sims

CAS Medical Systems, Inc. (NASDAQ:CASM) LogoInvestors sentiment increased to 1.4 in Q1 2018. Its up 0.40, from 1 in 2017Q4. It is positive, as 2 investors sold CAS Medical Systems, Inc. shares while 3 reduced holdings. 2 funds opened positions while 5 raised stakes. 6.50 million shares or 1.24% more from 6.42 million shares in 2017Q4 were reported.
Vanguard Grp Incorporated reported 532,365 shares. Northern Corporation owns 25,101 shares for 0% of their portfolio. 20 were accumulated by Royal Retail Bank Of Canada. Guggenheim Capital Ltd Llc has 12,246 shares for 0% of their portfolio. Hightower Ltd has 0% invested in CAS Medical Systems, Inc. (NASDAQ:CASM) for 240,889 shares. California Pub Employees Retirement Systems accumulated 10,400 shares. Wells Fargo Mn invested 0% of its portfolio in CAS Medical Systems, Inc. (NASDAQ:CASM). Penbrook Mngmt Ltd Liability reported 22,400 shares stake. Renaissance Technologies Ltd has 0% invested in CAS Medical Systems, Inc. (NASDAQ:CASM) for 262,600 shares. Rmb Llc holds 20,000 shares or 0% of its portfolio. Td Management Limited Liability Co holds 0.01% or 38,175 shares. Bankshares Of America De holds 0% or 541 shares in its portfolio. The New York-based Morgan Stanley has invested 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). Acuta Capital Prns Lc has 5.22 million shares for 1.07% of their portfolio. Horizon Kinetics invested in 99,546 shares.

Since March 15, 2018, it had 0 buys, and 4 sales for $44,489 activity.

Analysts expect CAS Medical Systems, Inc. (NASDAQ:CASM) to report $-0.07 EPS on August, 14.They anticipate $0.02 EPS change or 22.22 % from last quarter’s $-0.09 EPS. After having $-0.07 EPS previously, CAS Medical Systems, Inc.’s analysts see 0.00 % EPS growth. The stock increased 3.13% or $0.06 during the last trading session, reaching $1.98. About 237,436 shares traded or 49.91% up from the average. CAS Medical Systems, Inc. (NASDAQ:CASM) has risen 67.37% since July 14, 2017 and is uptrending. It has outperformed by 54.80% the S&P500.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $54.76 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

More news for CAS Medical Systems, Inc. (NASDAQ:CASM) were recently published by: Benzinga.com, which released: “Benzinga’s Daily Biotech Pulse: Sarepta’s DMD Gene Therapy, Anika’s Flunked Trial, Eidos To Commence Trading” on June 20, 2018. Investingnews.com‘s article titled: “Medical Device Update: Q2 2018 in Review” and published on July 12, 2018 is yet another important article.

CAS Medical Systems, Inc. (NASDAQ:CASM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: